SNAP23 Antibody

What is SNAP23 and why is it a significant target for antibody-based research?

SNAP23 (Synaptosomal-Associated Protein, 23kDa) is a 211-amino acid protein and a member of the SNAP-25 family. It serves as an essential component of the high-affinity receptor for general membrane fusion machinery and functions as a critical regulator of transport vesicle docking and fusion . SNAP23 facilitates the fusion of vesicles with target membranes by forming SNARE complexes, which are essential for exocytosis and endocytosis processes . Its membrane association and role in vesicular trafficking make it a valuable target for studying secretory pathways and membrane dynamics in various cell types.

What are the primary applications for SNAP23 antibodies in research?

SNAP23 antibodies are versatile tools employed across multiple research applications:

For optimal results, each antibody should be titrated in the specific experimental system being used .

How do I select the appropriate SNAP23 antibody for my research?

When selecting a SNAP23 antibody, consider the following criteria:

• Target species reactivity: Verify that the antibody reacts with your species of interest (human, mouse, rat, etc.)

• Application compatibility: Ensure the antibody is validated for your intended application (WB, IHC, ICC, etc.)

• Clonality: Choose between polyclonal (broader epitope recognition) or monoclonal (higher specificity) based on your needs

• Binding region: Some antibodies target specific regions (e.g., C-terminal region AA 192-211)

• Validation data: Review available validation data including western blots, immunostaining images, or knockout controls

• Citations: Consider antibodies with established publication records (e.g., some SNAP23 antibodies have been cited in up to 25 publications)

What are the optimal protocols for SNAP23 detection in Western blotting?

For effective Western blot detection of SNAP23:

• Sample preparation:

  • Use RIPA or NP-40 buffer supplemented with protease inhibitors

  • Expected molecular weight of SNAP23 is 23-25 kDa

• Electrophoresis conditions:

  • 12-15% SDS-PAGE gels provide optimal resolution for this protein size

  • Include positive control samples (e.g., HeLa or HepG2 cell lysates, which express detectable levels of SNAP23)

• Transfer and blocking:

  • PVDF membranes often yield better results than nitrocellulose for SNAP23

  • Block with 5% non-fat milk or BSA in TBST for 1 hour at room temperature

• Antibody incubation:

  • Primary antibody: Use at 1:500-1:2000 dilution (antibody-dependent)

  • Incubate overnight at 4°C for optimal signal-to-noise ratio

  • Secondary antibody: HRP-conjugated anti-host IgG at 1:5000-1:10000

• Validation controls:

  • siRNA knockdown experiments have confirmed antibody specificity

  • SNAP23 knockout cell lysates show signal elimination, confirming specificity

How should I optimize immunohistochemistry protocols for SNAP23 detection in tissue sections?

For effective IHC detection of SNAP23:

• Tissue preparation:

  • Both frozen and paraffin-embedded tissues are suitable

  • For paraffin sections, cut at 2-4 μm thickness

• Antigen retrieval:

  • For paraffin sections, use TE buffer pH 9.0 (preferred) or citrate buffer pH 6.0

  • Heat-induced epitope retrieval (HIER) at 95-98°C for 15-20 minutes

• Antibody incubation:

  • Dilute antibody 1:400-1:2000 depending on specific antibody and tissue

  • Incubate in a humidified chamber overnight at 4°C or 1-3 hours at room temperature

• Detection systems:

  • Use appropriate HRP-labeled or fluorescent secondary antibodies

  • DAB substrate for brightfield visualization or fluorescent secondary antibodies for IF

• Validated tissues:

  • Human placenta and prostate cancer tissues have been validated for many SNAP23 antibodies

  • SNAP23 has been shown to be selectively expressed in secretory but not ciliated cells of airway epithelium

How can I validate the specificity of SNAP23 antibodies in my experimental system?

To validate SNAP23 antibody specificity:

• Genetic approaches:

  • Use SNAP23 knockout cells/tissues as negative controls

  • Apply siRNA-mediated knockdown and verify signal reduction by Western blot

  • Multiple publications have successfully used these approaches for validation

• Peptide competition assays:

  • Pre-incubate antibody with immunizing peptide before application

  • Signal should be significantly reduced or eliminated

• Cross-reactivity testing:

  • Test against related proteins (e.g., other SNAP family members)

  • Many SNAP23 antibodies have been verified to have no cross-reactivity with other proteins

• Multiple antibody approach:

  • Use antibodies targeting different epitopes of SNAP23

  • Consistent results across different antibodies increase confidence in specificity

• Known expression patterns:

  • Compare results with established expression patterns (e.g., SNAP23 expression in secretory but not ciliated airway epithelial cells)

What are the most effective co-immunoprecipitation strategies for studying SNAP23 protein-protein interactions?

For successful co-immunoprecipitation of SNAP23 complexes:

• Lysis conditions:

  • Use mild non-denaturing buffers (e.g., 1% NP-40 or 0.5% Triton X-100)

  • Include phosphatase inhibitors to preserve interaction-relevant phosphorylation states

• Pre-clearing step:

  • Pre-clear lysates with appropriate control IgG and Protein A/G beads

  • Reduces non-specific binding and background

• Antibody selection:

  • Choose antibodies validated for IP applications (0.5-4.0 μg for 1.0-3.0 mg of total protein lysate)

  • Consider epitope location to avoid disrupting protein interactions

• Crosslinking considerations:

  • For transient interactions, consider mild crosslinking with DSP or formaldehyde

  • Optimize crosslinking time carefully to preserve specific interactions

• Controls:

  • Include IgG control IP to identify non-specific interactions

  • Include SNAP23-knockout/knockdown samples as negative controls

  • Consider reciprocal co-IP (IP with antibody against interacting partner)

What methodological approaches can resolve contradictory SNAP23 expression data in different tissues?

When facing contradictory SNAP23 expression data:

• Antibody validation strategies:

  • Use multiple antibodies targeting different epitopes of SNAP23

  • Verify antibody specificity using knockdown/knockout controls

  • Consider the immunogen sequence similarity across species for cross-reactivity concerns

• Tissue-specific considerations:

  • Use cell type-specific markers for co-localization (e.g., CCSP for club cells, acetylated α-tubulin for ciliated cells)

  • SNAP23 has been shown to be selectively expressed in secretory but not ciliated cells in airway epithelium

  • Cell-specific expression can be masked in whole-tissue analyses

• Methodological approaches:

  • Combine protein (WB, IHC) and mRNA (RT-PCR, RNA-seq) detection methods

  • Single-cell approaches may resolve heterogeneous expression in complex tissues

  • Complementary techniques: Both frozen and paraffin sections should be tested

• Quantification methods:

  • Use digital image analysis with appropriate controls

  • Normalize expression data to suitable housekeeping genes/proteins

  • Employ statistical analysis to determine significance of differences

How can I optimize SNAP23 detection in subcellular localization studies?

For precise subcellular localization of SNAP23:

• Fixation optimization:

  • Compare paraformaldehyde (4%) with methanol fixation

  • Membrane proteins like SNAP23 may require optimization of fixation time

• Permeabilization conditions:

  • Test different permeabilization agents (Triton X-100, saponin)

  • Membrane proteins often require gentler permeabilization

• Co-localization markers:

  • Use established markers for membrane compartments

  • Plasma membrane: Na+/K+-ATPase

  • Golgi apparatus: GM130

  • Recycling endosomes: Rab11

• Imaging techniques:

  • Standard confocal microscopy for general localization

  • Super-resolution techniques (STED, STORM) for precise membrane localization

  • Live cell imaging with fluorescently tagged SNAP23 for dynamics studies

• Data from validated studies:

  • SNAP23 has been successfully detected on cell surfaces in HepG2 human hepatocellular carcinoma cells

  • Specific staining localized to cell surfaces has been documented with verified antibodies

What are the optimal methodologies for studying SNAP23 in regulated secretion mechanisms?

To investigate SNAP23's role in regulated secretion:

• Secretion assay designs:

  • Measure regulated secretion before and after SNAP23 manipulation

  • Quantify secretory content release using appropriate markers

• Genetic manipulation approaches:

  • Use heterozygous SNAP23 mutant mice models (note: baseline mucin secretion is fully compensated by increased intracellular stores, but stimulated secretion may be affected)

  • siRNA knockdown in cellular models

  • CRISPR/Cas9 for complete or conditional knockout

• Stimulation protocols:

  • Test various secretagogues relevant to your system

  • Time-course experiments to distinguish immediate vs. sustained secretion phases

• Quantification methods:

  • ELISA for secreted products

  • Western blotting with loading controls

  • Fluorescent reporter systems for real-time monitoring

• Relevant research findings:

  • SNAP23 is selectively expressed in secretory but not ciliated cells of airway epithelium

  • Baseline mucin secretion in heterozygous mutant mice is fully compensated by increased intracellular stores

How can I optimize dual or multiple immunolabeling protocols involving SNAP23 antibodies?

For successful multiple immunolabeling with SNAP23:

• Antibody selection considerations:

  • Choose primary antibodies from different host species

  • If same-species antibodies must be used, consider direct conjugation or sequential detection

• Protocol optimization:

  • Sequential labeling may be required to prevent cross-reactivity

  • Test both simultaneous and sequential incubation of primary antibodies

• Control experiments:

  • Single-primary antibody controls to detect cross-reactivity

  • Secondary antibody-only controls to detect non-specific binding

  • Absorption controls with immunizing peptides

• Data from validated approaches:

  • Successful co-localization studies have been performed with SNAP23 and markers such as CCSP (for club cells) and acetylated α-tubulin (for ciliated cells)

  • Adjacent tissue slices can be stained with different antibodies to compare expression patterns

• Signal amplification:

  • Consider tyramide signal amplification for weak signals

  • Balance amplification with maintaining low background

What are the critical parameters for using SNAP23 antibodies in flow cytometry applications?

For successful flow cytometry applications with SNAP23 antibodies:

• Cell preparation:

  • Fixation: 2-4% paraformaldehyde (10-15 minutes)

  • Permeabilization: 0.1-0.5% saponin or 0.1% Triton X-100

• Antibody selection and validation:

  • Verify antibody compatibility with flow cytometry (FCM)

  • Test on positive control cells with known SNAP23 expression

• Staining protocol optimization:

  • Antibody concentration: Titrate to determine optimal signal-to-noise ratio

  • Incubation time and temperature: Usually 30-60 minutes at room temperature or 4°C

  • Blocking: 2-5% serum from secondary antibody host species

• Controls:

  • Isotype controls matching primary antibody class and concentration

  • Unstained cells to establish autofluorescence baseline

  • SNAP23 knockdown/knockout cells as negative controls

• Data analysis considerations:

  • Use appropriate gating strategies to isolate relevant cell populations

  • Consider co-staining with cell type-specific surface markers

How are SNAP23 antibodies being utilized in the study of disease mechanisms?

Recent research using SNAP23 antibodies in disease contexts:

• Cancer research applications:

  • SNAP23 expression has been studied in multiple cancer types

  • Validated antibodies have successfully stained human prostate cancer tissue

  • Investigation of SNAP23's role in cancer cell secretion and membrane dynamics

• Metabolic disease studies:

  • SNAP23 involvement in insulin-stimulated glucose transporter trafficking

  • Antibody-based co-localization studies with GLUT4 and insulin signaling components

• Respiratory system research:

  • SNAP23 is selectively expressed in airway secretory cells

  • Antibody staining shows distinct patterns in different airway epithelial cell types

  • Baseline mucin secretion in heterozygous mutant mice shows compensatory mechanisms

• Methodological considerations:

  • Select antibodies validated in disease-relevant tissues

  • Consider altered expression or localization in disease states

  • Include appropriate healthy and disease control samples

What are the technical considerations for comparing SNAP23 expression levels across different experimental conditions?

For accurate comparative analysis of SNAP23 expression:

• Sample standardization:

  • Standardize sample collection, processing, and storage procedures

  • Use identical protein/cell/tissue amounts across conditions

• Quantification methods:

  • Western blot: Use housekeeping proteins for normalization

  • IHC/ICC: Employ digital image analysis with standardized acquisition settings

  • Include standard curves when possible

• Statistical analysis:

  • Apply appropriate statistical tests based on data distribution

  • Account for biological and technical replicates

  • Consider power analysis to determine needed sample size

• Validation across methods:

  • Confirm protein-level changes with mRNA analysis

  • Use multiple antibodies targeting different epitopes

  • Consider absolute quantification methods when possible

• Controls for expression studies:

  • Include validated positive control samples (e.g., HeLa or HepG2 cells)

  • Use SNAP23 knockout/knockdown samples as negative controls